✦ LIBER ✦

Buyers’ Miscoordination, Entry and Downstream Competition

✍ Scribed by Chiara Fumagalli; Massimo Motta

Book ID: 111056060
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 676 KB
Volume: 118
Category: Article
ISSN: 0013-0133
DOI: 10.1111/j.1468-0297.2008.02166.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Buyer Alliances and Managed Competition

✍ Yeon-Koo Che; Ian Gale 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Downstream Competition, Bargaining, and

Downstream Competition, Bargaining, and Welfare

✍ George Symeonidis 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Downstream Competition, Foreclosure, and

Downstream Competition, Foreclosure, and Vertical Integration

✍ Gilles Chemla 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Local competition, entry, and agglomerat

Local competition, entry, and agglomeration

✍ Ting Zhu; Vishal Singh; Anthony Dukes 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 355 KB

Network Competition and Entry Deterrence

✍ Joan Calzada; Tommaso M. Valletti 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Entry and competition in generic biologi

Entry and competition in generic biologics

✍ Henry G. Grabowski; David B. Ridley; Kevin A. Schulman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

## Abstract Patents for several blockbuster biological products are expected to expire soon. The Food and Drug Administration is examining whether biologics can and should be treated like pharmaceuticals with regard to generics. In contrast with pharmaceuticals, which are manufactured through chemi